The Search for Better Obesity Treatments
Punit Dhillon, president and CEO of Skye Bioscience, discusses the limits of GLP-1 obesity therapies, the company’s experimental obesity therapy that ...
A Novel Approach to Treating Chronic Low Back Pain
Many companies are seeking to develop non-opioid treatments for pain, but Persica Pharmaceuticals may be taking a surprising approach for chronic low-...
A Biologic Designed to Treat Acute Exacerbations of Asthma and COPD
Though there are plenty of therapeutic alternatives for asthma and chronic obstructive pulmonary disease, or COPD, there are no approved biologics for...
Turbocharging Drug Discovery with Health Data
When Vanderbilt University Medical Center began to consider how big data and precision medicine were going to impact both research and development and...
Revolutionizing the Production of Biologics with Algae
Spirulina, also known as blue-green algae, is edible. It can be engineered to cost-effectively produce biologics that can be taken orally. Though peop...
Making Medicines for a World of People with Cancer
Cancer is a global disease, and BeOne Medicines believes it should develop its cancer therapies for global markets. To do so, it’s taking innovative a...
Harnessing Myeloid Cells to Attack Cancer
The advent of immunotherapies is transforming cancer care. While early efforts have focused on enabling T cells to attack cancers, Myeloid Therapeutic...
Drawing Lessons from the COVID Pandemic
Despite having taken steps to prepare for a possible pandemic, the United States fared poorly during the COVID outbreak relative to other developed na...
A Bet that Myostatins Can Muscle Out Obesity
GLP-1 agonists have been a breakthrough for the treatment of obesity, a global problem with serious health risks. While the benefits of these therapie...
Making Whole-Eye Transplantation a Reality
At the end of 2024, the Advanced Research Projects Agency for Health awarded a team led by the University of Colorado Anschutz Medical Campus, and inc...